{"id":"https://openalex.org/W1940810331","doi":"https://doi.org/10.3265/nefrologia.pre2014.feb.12506","title":"Role of monoclonal antibodies in the treatment of immune-mediated glomerular diseases.","display_name":"Role of monoclonal antibodies in the treatment of immune-mediated glomerular diseases.","publication_year":2014,"publication_date":"2014-05-21","ids":{"openalex":"https://openalex.org/W1940810331","doi":"https://doi.org/10.3265/nefrologia.pre2014.feb.12506","mag":"1940810331","pmid":"https://pubmed.ncbi.nlm.nih.gov/24798567"},"language":"en","primary_location":{"id":"pmid:24798567","doi":"https://doi.org/10.3265/nefrologia.pre2014.feb.12506","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24798567","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031943687","display_name":"Joaqu\u00edn Manrique","orcid":"https://orcid.org/0000-0002-7713-1629","observed_orcids":["https://orcid.org/0000-0002-7713-1629"]},"institutions":[{"id":"https://openalex.org/I4210097920","display_name":"Complejo Hospitalario de Navarra","ror":"https://ror.org/011787436","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210097920"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Joaqu\u00edn Manrique","raw_affiliation_strings":["Complejo Hospital de Navarra, Pamplona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Complejo Hospital de Navarra, Pamplona, Spain","institution_ids":["https://openalex.org/I4210097920"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005075162","display_name":"Paolo Cravedi","orcid":"https://orcid.org/0000-0001-7837-0923","observed_orcids":["https://orcid.org/0000-0001-7837-0923"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paolo Cravedi","raw_affiliation_strings":["Icahn School of Medicine at Mount Sinai , New York , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Icahn School of Medicine at Mount Sinai , New York , USA","institution_ids":["https://openalex.org/I98704320"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.1096,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.85078819,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"34","issue":"3","first_page":"388","last_page":"97"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10697","display_name":"Vasculitis and related conditions","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9950000047683716},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9940000176429749},{"id":"https://openalex.org/keywords/cd20","display_name":"CD20","score":0.7910000085830688},{"id":"https://openalex.org/keywords/b-cells","display_name":"B cells","score":0.7490000128746033},{"id":"https://openalex.org/keywords/eculizumab","display_name":"eculizumab","score":0.8610000014305115},{"id":"https://openalex.org/keywords/complement-c5","display_name":"complement C5","score":0.6610000133514404},{"id":"https://openalex.org/keywords/membranous-nephropathy","display_name":"membranous nephropathy","score":0.8370000123977661},{"id":"https://openalex.org/keywords/minimal-change-disease","display_name":"minimal change disease","score":0.9929999709129333},{"id":"https://openalex.org/keywords/focal-segmental-glomerulosclerosis","display_name":"focal segmental glomerulosclerosis","score":1.0},{"id":"https://openalex.org/keywords/nephrotic-syndrome","display_name":"nephrotic syndrome","score":0.9580000042915344},{"id":"https://openalex.org/keywords/anca-associated-vasculitis","display_name":"ANCA-associated vasculitis","score":0.9950000047683716},{"id":"https://openalex.org/keywords/lupus-nephritis","display_name":"lupus nephritis","score":0.996999979019165},{"id":"https://openalex.org/keywords/mixed-cryoglobulinemia","display_name":"mixed cryoglobulinemia","score":0.9819999933242798},{"id":"https://openalex.org/keywords/atypical-hemolytic-uremic-syndrome","display_name":"atypical hemolytic uremic syndrome","score":0.9860000014305115},{"id":"https://openalex.org/keywords/membranoproliferative-glomerulonephritis","display_name":"membranoproliferative glomerulonephritis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.734000027179718},{"id":"https://openalex.org/keywords/autoantibodies","display_name":"autoantibodies","score":0.7369999885559082},{"id":"https://openalex.org/keywords/immunosuppressant-toxicity","display_name":"immunosuppressive drug toxicity","score":0.6959999799728394}],"concepts":[{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.8145431280136108},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7976424098014832},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6866945028305054},{"id":"https://openalex.org/C2777991916","wikidata":"https://www.wikidata.org/wiki/Q421617","display_name":"Eculizumab","level":4,"score":0.6565558910369873},{"id":"https://openalex.org/C2775946357","wikidata":"https://www.wikidata.org/wiki/Q1713037","display_name":"Membranous nephropathy","level":4,"score":0.6450281739234924},{"id":"https://openalex.org/C2781036514","wikidata":"https://www.wikidata.org/wiki/Q2299379","display_name":"Membranoproliferative glomerulonephritis","level":4,"score":0.5894172787666321},{"id":"https://openalex.org/C2779912601","wikidata":"https://www.wikidata.org/wiki/Q1621830","display_name":"Lupus nephritis","level":3,"score":0.5811649560928345},{"id":"https://openalex.org/C2778415529","wikidata":"https://www.wikidata.org/wiki/Q1435223","display_name":"Focal segmental glomerulosclerosis","level":4,"score":0.5532907843589783},{"id":"https://openalex.org/C2780368995","wikidata":"https://www.wikidata.org/wiki/Q605006","display_name":"Glomerulonephritis","level":3,"score":0.5401948690414429},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5270807147026062},{"id":"https://openalex.org/C2778930706","wikidata":"https://www.wikidata.org/wiki/Q504790","display_name":"Nephrotic syndrome","level":2,"score":0.5077646970748901},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.46838241815567017},{"id":"https://openalex.org/C2781184683","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Nephropathy","level":3,"score":0.4433761239051819},{"id":"https://openalex.org/C2777747828","wikidata":"https://www.wikidata.org/wiki/Q1323002","display_name":"Minimal change disease","level":5,"score":0.4282502233982086},{"id":"https://openalex.org/C2777637130","wikidata":"https://www.wikidata.org/wiki/Q17165460","display_name":"Atypical hemolytic uremic syndrome","level":4,"score":0.41060811281204224},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3926224410533905},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3011319935321808},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22285008430480957},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.14182955026626587},{"id":"https://openalex.org/C111684460","wikidata":"https://www.wikidata.org/wiki/Q334848","display_name":"Complement system","level":3,"score":0.1331041157245636},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.09151831269264221},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001327","descriptor_name":"Autoimmune Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007674","descriptor_name":"Kidney Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007674","descriptor_name":"Kidney Diseases","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D007678","descriptor_name":"Kidney Glomerulus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:24798567","doi":"https://doi.org/10.3265/nefrologia.pre2014.feb.12506","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24798567","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia","raw_type":"Journal Article"},{"id":"pmh:oai:scielo:S0211-69952014000300016","doi":null,"is_oa":false,"landing_page_url":"http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-69952014000300016","pdf_url":null,"source":{"id":"https://openalex.org/S4306402135","display_name":"Scientific Electronic library online (Sciences Carlos III Health Institute)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801357902","host_organization_name":"Instituto de Salud Carlos III","host_organization_lineage":["https://openalex.org/I2801357902"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Nefrolog\u00c3\u00ada (Madrid) v.34 n.3 2014","raw_type":"journal article"},{"id":"mag:1940810331","doi":"https://doi.org/10.3265/nefrologia.pre2014.feb.12506","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24798567","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":51,"referenced_works":["https://openalex.org/W1569990619","https://openalex.org/W1577181385","https://openalex.org/W1913987183","https://openalex.org/W1964913193","https://openalex.org/W1983962997","https://openalex.org/W1985590116","https://openalex.org/W1989273660","https://openalex.org/W1992627136","https://openalex.org/W2002032734","https://openalex.org/W2002364878","https://openalex.org/W2007500736","https://openalex.org/W2008615274","https://openalex.org/W2012630248","https://openalex.org/W2018799387","https://openalex.org/W2023377972","https://openalex.org/W2023435387","https://openalex.org/W2044713055","https://openalex.org/W2044784043","https://openalex.org/W2046330020","https://openalex.org/W2051266349","https://openalex.org/W2051293525","https://openalex.org/W2053683902","https://openalex.org/W2053803732","https://openalex.org/W2060207582","https://openalex.org/W2063694399","https://openalex.org/W2069649947","https://openalex.org/W2071219763","https://openalex.org/W2076316204","https://openalex.org/W2084056567","https://openalex.org/W2089916413","https://openalex.org/W2092013057","https://openalex.org/W2096606489","https://openalex.org/W2107516496","https://openalex.org/W2108646369","https://openalex.org/W2110192851","https://openalex.org/W2111077593","https://openalex.org/W2112830170","https://openalex.org/W2112988722","https://openalex.org/W2122581834","https://openalex.org/W2124215501","https://openalex.org/W2131457901","https://openalex.org/W2133736867","https://openalex.org/W2134425923","https://openalex.org/W2141219630","https://openalex.org/W2157296439","https://openalex.org/W2162452494","https://openalex.org/W2164755825","https://openalex.org/W2167795729","https://openalex.org/W2171643265","https://openalex.org/W2318607717","https://openalex.org/W2330016901"],"related_works":["https://openalex.org/W2568456128","https://openalex.org/W2116975025","https://openalex.org/W2043782712","https://openalex.org/W7140118288","https://openalex.org/W7217828665","https://openalex.org/W7151998988","https://openalex.org/W4382864201","https://openalex.org/W1971064823","https://openalex.org/W4411371946","https://openalex.org/W4415434705"],"abstract_inverted_index":{"Non-specific":[0],"immunosuppressants":[1],"have":[2,53,109],"represented":[3],"for":[4,9,184,188],"decades":[5],"the":[6,33,48,63,112,115,169],"only":[7],"therapies":[8],"patients":[10,73,145,190],"with":[11,20,74,146],"immune-mediated":[12],"glomerular":[13,51,147,172],"diseases.":[14,148,173],"These":[15],"treatments,":[16],"however,":[17,178],"are":[18,26,138,162],"associated":[19],"high":[21,176],"rates":[22],"of":[23,35,50,114,155,168,171],"no-response":[24],"and":[25,104,129,158],"burdened":[27],"by":[28],"toxicities":[29],"that":[30],"frequently":[31],"offset":[32],"benefits":[34],"proteinuria":[36,71],"reduction.":[37],"Monoclonal":[38],"antibodies":[39,161],"targeting":[40],"selective":[41],"cell":[42],"populations":[43],"or":[44,84],"mediators":[45],"implicated":[46],"in":[47,72,164,191],"pathophysiology":[49,170],"diseases":[52],"recently":[54],"become":[55],"available.":[56],"Rituximab,":[57],"a":[58,181],"chimeric":[59],"monoclonal":[60,118,160],"antibody":[61,119],"against":[62],"CD20":[64],"antigen":[65],"on":[66],"B":[67],"cells,":[68],"safely":[69],"reduced":[70],"nephrotic":[75],"syndrome":[76],"secondary":[77],"to":[78,90,97,121,133,143,151],"membranous":[79],"nephropathy,":[80,128],"minimal":[81],"change":[82],"disease,":[83],"focal":[85],"segmental":[86],"glomerulosclerosis.":[87],"Its":[88],"ability":[89],"reduce":[91],"auto-antibody":[92],"formation":[93],"has":[94],"been":[95],"instrumental":[96],"treat":[98,122,144],"also":[99,110],"ANCA-associated":[100],"vasculitis,":[101],"lupus":[102],"nephritis,":[103],"mixed":[105],"cryoglobulinemia.":[106],"Many":[107],"reports":[108],"documented":[111],"efficacy":[113],"anti-C5":[116],"humanized":[117],"Eculizumab":[120],"atypical":[123],"hemolytic":[124],"uremic":[125],"syndrome,":[126],"C3":[127],"membranoproliferative":[130],"glomerulonephritis.":[131],"Thanks":[132],"these":[134,157],"encouraging":[135],"findings,":[136],"monoclonals":[137],"becoming":[139],"very":[140],"helpful":[141],"tools":[142],"Moreover,":[149],"thanks":[150],"their":[152,185],"specific":[153],"mechanism":[154],"action,":[156],"other":[159],"important":[163],"improving":[165],"our":[166],"understanding":[167],"Their":[174],"still":[175],"costs,":[177],"might":[179],"represent":[180],"major":[182],"hurdle":[183],"widespread":[186],"implementation":[187],"all":[189],"need.":[192]},"counts_by_year":[{"year":2023,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}